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Rat sexual maturation is preceded by a reduction of the interpulse interval (IPI) of gonadotropin-
releasing hormone (GnRH) neurosecretion. This work aims at studying disruption of that neu-
roendocrine event in females after early exposure to a very low dose of Bisphenol A (BPA), a
ubiquitous endocrine disrupting chemical.
Female rats were exposed to vehicle or BPA 25 ng/kg.day, 25 g/kg.day, or 5 mg/kg.day from
postnatal day (PND) 1 to 5 or 15. Exposure to 25 ng/kg.day of BPA for 5 or 15 days was followed
by a delay in developmental reduction of GnRH IPI studied ex vivo on PND 20. After 15 days of
exposure to that low dose of BPA, vaginal opening tended to be delayed. In contrast, exposure to
BPA5mg/kg.day for 15days resulted inapremature reduction inGnRH IPI anda trend towardearly
vaginal opening. RNAseq analysis on PND20 indicated that exposure to BPA resulted in opposing
doseeffectson themRNAexpressionofhypothalamicgenes involved inGABAAneurotransmission.
The study of GnRH secretion in vitro in the presence of GABAA receptor agonist/antagonist con-
firmed an increased or a reducedGABAergic tone after in vivo exposure to the very lowor the high
dose of BPA, respectively.
Overall, we show for the first time that neonatal exposure to BPA leads to opposing dose-depen-
dent effects on the neuroendocrine control of puberty in the female rat. A very low and environ-
mentally relevant dose of BPA delays neuroendocrine maturation related to puberty through
increased inhibitory GABAergic neurotransmission.
Bisphenol A (BPA), a most ubiquitous Endocrine Dis-rupting Chemical (EDC), is used in the production of
polycarbonate plastics and epoxy resins (1). In a recent
review of thirteen studies addressing the issue of BPA ef-
fects on female rodent sexual maturation (2), exposure
during the first two weeks after birth was associated with
either normal (3–6) or early vaginal opening (4, 6–8) de-
pending on the dose of BPA but without consistent dose-
response effect. None among those studies found puberty
to be delayed. A neuroendocrine mechanism was sug-
gested in some studies (7, 9) and invalidated in others (4).
In the 13 studies summarized in the above-mentioned re-
view, BPA was used in the g/kg.day or mg/kg.day body
weight rangesofdaily exposure (2). So far, pubertal timing
had never been studied after BPA administration in the
ng/kg.day range which is consistent with current human
exposure (0.01 to 1g/kg.day) (10). In humans, equivocal
data have been obtained. BPA excretion was not associ-
ated with changes in pubertal timing in several studies
(11–13). Increased urinary BPA levels were observed ei-
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ther in precocious puberty (14) or in relation with late
menarche (15). The purpose of the present study was to
further elucidate the impact of the dose of BPA on female
puberty and the underlying neuroendocrine mechanism
with emphasis on rat exposure to low environmentally
relevant doses during the early postnatal window. The
mechanistic issue was addressed using an ex vivo para-
digm of pulsatile GnRH secretion from hypothalamic ex-
plants (16) that was shown to be affected by other EDCs
in previous studies (17, 18).
The effects of EDCs on female puberty can result either
from peripheral effects at the level of estrogen sensitive
tissues eg, breast, uterus and vagina or from an activation
of the hypothalamic-pituitary-ovarian axis (19, 20). The
question arises as to whether early life exposure to BPA
can affect the neuroendocrine control of puberty. During
perinatal life, a critical window for organization of the
central control of the reproductive axis, the female neu-
roendocrine system is particularly sensitive to sex steroids.
In previous studies, we have shown that a single estradiol
administration caused central sexual precocity and dis-
rupted the central mechanism of ovulation (21). Also,
early postnatal exposure of female rats to the estrogenic
insecticide dichlorodiphenyltrichloroethane (DDT) re-
sulted in early neuroendocrine maturation with preco-
cious vaginal opening (VO) (17). Neonatal exposure to
DES for 5 days was also associated with early puberty
following a dose of 10 g/kg.day and, unexpectedly, with
a delayed puberty preceded by a delayed maturation of
GnRH secretion after 1 g/kg.day of DES (18).
Since we used exposure to DES for 5 days during the
neonatal programming window in our previous study, a
similar window of exposure was used initially for BPA. In
such conditions, effects onGnRHsecretionwere observed
after exposure to 25 ng/kg.day and 5 mg/kg.day whereas
no effect was seen using 25 g/kg.day. None of the three
doses was associated with differences in pubertal timing.
Therefore, we studied the effects of a longer exposure (15
days) to the lowest and the highest doses in further exper-
iments. For the first time in investigating puberty, we used
a very low dose of BPA of (25 ng/kg.day), which is an
equivalent lowdose of environmental exposure in humans
(10). The delaying effects of this low dose on developmen-
tal changes in GnRH secretion and puberty were opposed
to the acceleration seen after exposure to 5 mg/kg.day.
This contrast provided the rationale for RNAseq study to
delineate possible opposing changes in mRNA expression
of some hypothalamic genes involved in the maturational
control of GnRH secretion. It appeared that the most sig-
nificantly affected genes were related to GABA neu-
rotransmission, a finding confirmed using quantitative
PCR (qPCR). The involvement was interesting given the
developmental reduction in inhibitory GABA control of
GnRH secretion that was substantiated in the primate in
the period preceding the onset of puberty (22, 23) and also
shown to occur in the rat using our hypothalamic explant
paradigm (24, 25).
Materials and Methods
Animal care and exposure
Female Wistar rats were purchased from the University of
Liège. They were housed in standardized conditions (22.8°C,
lights on from 6.30 am to 6.30 pm) and mated. Litters were
standardized for size and sex ratio on the first postnatal day of
life in order to have 10–12 pups per litter and an identical num-
ber of males and females. The day of birth was considered as
postnatal day 1.Weaning occurred at 21 days of age. In order to
avoid a litter effect, a maximum of two pups coming from the
same dam were studied in a same group for a given experiment.
In each litter, female pups were exposed either to corn oil or to
one of the three BPA doses. The animals were raised in BPA-free
cages (Polypropylene cages, Ref 1291H006, Tecnilab, Nether-
lands) and fed EDC- and phytoestrogen-free chow (V135 R/Z
low phytoestrogen pellets, SSNIFF Diet, Netherlands). Water
was supplied in glass bottles. Beginning on PND 1, female pups
were subcutaneously injected with vehicle (corn oil) or BPA 25
ng/kg.day (consistent with low environmental exposure) or 5
mg/kg.day (10 times below LOAEL – Low observed adverse
effect level) or an intermediate dose of 25 g/kg.day. BPA (Ref:
23,9658; Sigma–Aldrich, Saint Louis, USA)was dissolved in eth-
anol at an initial concentration of 100mg/ml and then diluted in
corn oil. Injections (0.05ml) were given every 24 hours, between
11.00 am and 1.00 pm, from PND 1 to 5 or from PND 1 to 15.
All experimentswere carriedoutwith the approval of theBelgian
Ministry of Agriculture and the Ethical Committee at the Uni-
versity of Liège.
Experimental design
Effects of exposure to BPA from PND 1 to 5 on pubertal
timing and GnRH secretion. Ninety female pups from 16
dams were exposed from PND 1 to 5 to corn oil, 25 ng, 25g or
5 mg/kg.day of BPA. Females were sacrificed on PND 15 (n 
16), 20 (n 12), or 25 (n 8) to study GnRH secretion ex vivo
(4 animals/ BPA dose group) while 54 animals were followed for
VO and estrous cyclicity (n  6–14/ BPA dose group and 21
controls).
Effects of exposure to BPA from PND 1 to 15 on pubertal
timing, GnRH secretion and hypothalamic gene
expression. One hundred and four female pups born from 18
damswere exposed to cornoil, 25ngor5mg/kg.dayofBPA from
PND 1 to 15. Thirty-four females were followed for VO/estrus
cyclicity (n 8–14/group) while 46 were sacrificed on PND 20
to study GnRH secretion ex vivo. Explants were incubated in
control medium or in the presence of 10-4M of bicuculline
(B7561, Sigma) or muscimol (M1523, Sigma) (25) (n  4 to
10/group). In 24 females also sacrificed on PND 20, the retro-
chiasmatic hypothalamuswas dissected andRNAwas extracted
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for RNA sequencing or real-time PCR (n  8/control and each
BPA dose group). In Supplemental Table 1, the number of ani-
mals per experiment is specified.
Vaginal opening and estrous cyclicity
From PND 25, female rats were examined daily for imper-
forationof the vaginalmembrane todetermine age atVO.There-
after, vaginal smears were taken every day in the afternoon until
PND80as describedpreviously (18).A regular cyclewas defined
by a regular sequence of diestrus 1, diestrus 2, proestrus and
estrus (26).
Hypothalamic explant incubation and GnRH assay
GnRHpulse frequencywas studied throughcalculationof the
interpulse interval (IPI) using GnRH release from female rat hy-
pothalamic explants. GnRH secretion was studied after expo-
sure to different doses of BPA from PND 1 to 5 or 15 (Supple-
mental Table 1). After exposure to corn oil (control) or different
doses of BPA fromPND1 to 5, 16 explantswere studied on PND
15 (corn oil and BPA 25 ng, 25 g or 5 mg/kg.day) and 12
explants on PND 20 after exposure to the low (25 ng/kg.day) or
the high (5 mg/kg.day) dose of BPA. Eight explants were also
studied on PND 25 after exposure to the low dose of BPA (25
ng/kg.day) from PND 1 to 5. After a longer exposure (PND 1 to
15) to the low (25 ng/kg.day) or the high (5 mg/kg.day) dose of
BPA, explants were studied on PND 20 (8 controls, 16 low dose
of BPA and 22 high dose). The GnRH IPI was studied in the
presence of a GABAA receptor agonist, muscimol (10
-4 M) and
an antagonist, bicuculline (10-4 M). In previous in vitro studies
using hypothalamic explants, a high GABAergic inhibitory tone
on GnRH release was revealed by a reduction of the IPI in the
presence of the antagonist bicuculline on PND 15. On PND 25,
a lowered GABAergic tone was suggested by the disappearance
of bicuculline effects and the occurrence of an increase in GnRH
IPI caused by the agonist muscimol (24, 25). We used the same
conditions here including bicuculline and muscimol concentra-
tions (10-4M), to investigate the effects of BPA on the regulation
of GnRH secretion by GABAergic neurotransmission.
After decapitation, a tissue fragment including the preoptic
region and themedial basal hypothalamuswas rapidly dissected,
as described in supplementary data. Each explant was trans-
ferred into an individual chamber in a static incubator (21). The
incubationmediumwas collectedand renewedevery7.5minutes
for a period of 4 hours. The GnRH release in the incubation
medium was measured in duplicate using a radioimmunoassay
(RIA) method with intra-assay and interassay coefficients of
variation of 14% and 18%, respectively (27, 28). The highly
specific CR11-B81 anti-GnRH antiserum (final dilution
1:80,000)waskindlyprovidedbyDr.V.D.Ramirez (Urbana, IL)
(29). The properties of this antibody are given in Table 1. Data
below the limit of detection (5 pg/7.5-minute fraction) were as-
signed that value.
RNA sequencing
RNAseq analysis was carried out on total RNA extracted
from retrochiasmatic hypothalamus of female rats on PND 20
(control: n  3; BPA 25 ng: n  3; BPA 5 mg: n  3). Previous
studies have shown that the retrochiasmatic hypothalamus con-
tains neurono-glial networks involved in the regulation of pul-
satileGnRHsecretion (24, 25, 30).The extractionwasdonewith
theRNeasyMini kit (Qiagen,Netherlands). Library preparation
and sequencing were performed at the GIGA Genomics facility
(University of Liège, Belgium). RNA integritywas verified on the
Bioanalyser 2100 with RNA 6000 Nano chips, RIN scores
were 8 for all samples. Illumina Truseq strandedmRNA Sam-
ple Preparation kit was used to prepare libraries from 1 g of
total RNA. Poly-A RNAswere purified with polyT-coatedmag-
netic beads and chemically fragmented. They were used as tem-
plate for first strand synthesis in the presence of random hex-
amers followed by second strand synthesis. cDNA ends were
adenylated at 3OH extremities before the ligation to adaptors
containing the indexes. Finally, the adapters-ligated library frag-
ments were enriched by PCR following Illumina’s protocol and
purified with Ampure XP magnetic beads. Libraries were vali-
dated on Bioanalyser DNA 1000 chip and quantified by qPCR
with the KAPA library quantification kit. Sequencing was per-
formed on Illumina NextSeq500. For the data analysis, Fastq
fileswere trimmed for adaptor sequences.The readswere aligned
with Tophat 2.0.9 (http://ccb.jhu.edu/software/tophat/index-
.shtml) to the rat genome. The number of reads per sample was
between 11.106 and 22.106. The overall read aligment rate was
between 77.7 to 83%. Cufflinks 2.2.0 suite (http://cole-trapnell-
lab.github.io/cufflinks/manual/)was used to generate Fragments
PerKilobaseof transcript permillion fragmentsmapped (FPKM)
values and CuffDiff was used to identify significantly differen-
tially expressed genes between the 3 conditions of treatment (q-
value, ie, corrected p value  0.05). The data are presented in
log2 (fold change) to allow a representation of an increase as a
positive value and a decrease as a negative value on a single plot.
More details concerning these softwares and their analytical and
statistical methods are given in supplemental materials and
methods (31).
Data Mining Analysis
In order to identify the pathways most affected by BPA, sig-
nificant RNAseq data were uploaded onQIAGEN’s Ingenuity®
Pathway Analysis (IPA®, QIAGEN Redwood City, www.q-
iagen.com/ingenuity). Canonical pathway analysis was per-
formed on genes with a p-value  0.05 in order to identify the
pathways most affected by BPA. More information concerning
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Real-time PCR
Quantitative PCR (qPCR) analysis was used to assess mRNA
levels ofGAD2andGAT2onPND20 (n8/group). TotalRNA
was extracted from retrochiasmatic hypothalamus of female rats
using the RNeasyMini kit (Qiagen, Netherlands). Five hundred
nanograms of RNA for each sample were reverse transcripted
using the Transcriptor first strand cDNA synthesis kit (Roche,
Germany). Real-time quantitative PCR reactions were per-
formed using FastStart Universal SYBR Green Master (Rox)
(Roche, Germany) and a LightCycler 480 system (Roche, Ger-
many). Samples were run in triplicate. Fourmicroliters of cDNA
(previously 5-fold diluted) were added to a mix of 5 l of Sybr
green, 0.3 l of both forward and reverse primers and 0.4 l of
nuclease-free water. Ct values were obtained from each individ-
ual amplification curve and the average Ct was calculated for
each target gene in each sample. Quantification of relative gene
expression was performed according to the 2-Ct method using
-actin as housekeeping gene (32). The primers sequences and
information are provided in Supplemental Table 2.
Statistics
Numerical values were expressed as mean  SEM. For the
analysis of GnRH IPI and mRNA expression (after RTqPCR),
we performed a Student’s t test to compare two groups of the
same age. For data sets containing more than two groups of the
same age, a one-way ANOVA followed by a Newman–Keuls
multiple test was used. To compare more than two groups at
different ages, a two-way ANOVA followed by a Newman–
Keuls multiple test was used. To analyze the age at VO, a Cox
regression model was applied. This model is an adaptation of
probit analyses commonly used to study pubertal onset in hu-
mans (33). Probit analysis is a type of regression used with bi-
nomial response variable (in this study: vaginal opening, yes/no).
Differences with a p value lower than 0.05were considered to be
statistically significant. Statistical analyses were carried out us-
ing Statistica® software.
Results
Pubertal timing after exposure to BPA from PND 1
to 5
In agreement with our previous findings (16), matura-
tion of GnRH secretion preceding puberty was character-
ized by a reduction of the GnRH IPI between PND 15 and
PND25 (Figure 1) using hypothalamic explants of control
female rats ex vivo. Exposure to 25ng/kg.day of BPA from
PND 1 to 5 resulted in a significant increase of GnRH IPI
onPND20and25, consistentwith delayedmaturation. In
contrast, exposure to 5 mg/kg.day of BPA resulted in a
significant reduction of GnRH IPI on PND 15 and 20,
consistent with advanced maturation. The intermediate
dose of 25g/kg.day did not affectGnRH IPI. Though the
low dose of BPA caused a slight delay of age at VO (Figure
1), there was no significant difference between age at VO
among the 4 groups (control, BPA 25 ng/kg.day, BPA 25
g/kg.day, BPA 5 mg/kg.day). The BPA-exposed animals
showed normal estrous cyclicity from vaginal opening un-
til PND 80. No significant difference in average weight
was observed between the control and BPA groups from
PND 1 to 90.
Pubertal timing after exposure to BPA from PND 1
to 15
After a longer exposure (fromPND1 to 15), theGnRH
IPI on PND20was significantly increased by the low dose
of BPA and reduced by the high dose (Figure 2), similarly
to the effects observed after a shorter exposure. As illus-
trated by the cumulative percentage curves in Figure 2
(panelA), exposure to the lowdose of BPA tended to delay
VOwhile the highdose ofBPA tended to advanceVO.The
Cox regression regarding age at VO revealed a significant
difference (P  .016) between the three groups (control,
BPA 25ng/kg.day, BPA 5 mg/kg-
.day). Pair analysis indicated that the
difference was only significant be-
tween the groups exposed to the low
and high doses of BPA (P  .0043)
and not when these exposed groups
were compared to controls (Figure
2). The BPA-exposed animals exhib-
ited normal estrous cyclicity from
vaginal opening until PND 80. No
significant difference in average
weight was observed between the
control andBPAgroups fromPND1
to 90, suggesting that differences in
maturation of GnRH secretion and
pubertal timing did not result from
differences in nutritional status.
Figure 1. Effects of postnatal BPA exposure for 5 days on pulsatile GnRH secretion and female
pubertal timing. A, GnRH IPI in vitro using hypothalamic explants obtained on PND 15, 20 or 25
from female rats after exposure from PND 1 to 5 to vehicle, 25 ng/kg.day, 25 g/kg.day or 5 mg/
kg.day of BPA. B, Age at vaginal opening in female rats exposed from PND 1 to 5 to vehicle, 25
ng/kg.day, 25 g/kg.day or 5 mg/kg.day of BPA. Data are mean  SEM; *P  .05 and ***P 
.001 vs control at the same age; £££ P  .001 vs control at PND 15.
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BPA exposure and changes in
hypothalamic mRNA expression
In order to identify the hypotha-
lamic genes possibly involved in the
dose-related opposing effects of BPA
on GnRH secretion and pubertal
timing, aRNA sequencing studywas
performed using retrochiasmatic hy-
pothalamic extracts obtained on
PND 20 in female rats. After expo-
sure to BPA 25 ng/kg.day and 5 mg/
kg.day (PND 1–15), the mRNA ex-
pression of 34 and 472 genes was
significantly affected, respectively
(q-value  0.05 vs controls). When
comparing the two BPA doses, 1407
genes were differentially expressed.
A bioinformatic analysis (Ingenuity
Pathway Analysis) revealed that
GABAA receptor neurotransmission
was among the systems most af-
fected by both doses of BPA (Figure
3), based on both the number of af-
fected genes and the statistical signif-
icance of changes in expression. The
10canonical pathwaysmost affected
Figure 2. Effects of postnatal BPA exposure for 15 days on pulsatile GnRH secretion and female
pubertal timing. A, Cumulative percentage of female rats displaying vaginal opening in relation
to age in animals exposed from PND 1 to 15 to vehicle or 25 ng/kg.day or 5 mg/kg.day of BPA.
Mean age at VO  SEM for each group is indicated in brackets. B, GnRH IPI in vitro using
hypothalamic explants obtained on PND 20 from female rats after exposure from PND 1 to 15 to
vehicle or 25 ng/kg.day or 5 mg/kg.day of BPA. Data are mean  SEM. *** P  .001, vs control
group. C, and (D) Individual representative profiles of GnRH secretion after neonatal exposure to
vehicle or BPA 25 ng/kg.day or 5 mg/kg.day.
Figure 3. Hypothalamic pathways affected by 25 ng or 5 mg/kg.day of BPA. A. Top 10 canonical pathways derived from Ingenuity Pathway
Analysis based on genes that are significantly down- or upregulated in the retrochiasmatic hypothalamus on PND 20 after 15 days of exposure to
BPA 25 ng/kg.day. B. Top 10 canonical pathways derived from Ingenuity Pathway Analysis based on genes that are significantly down- or
upregulated in retrochiasmatic hypothalamus on PND 20 after 15 days of exposure to BPA 5 mg/kg.day. The pathways are ranked based on –log
(p-value) in order of decreasing significance that is illustrated by the bold line. The black and the white bars refer to the percentage of upregulated
and downregulated genes that is calculated relative to the total number of genes involved in each pathway (given in the brackets).
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by the two doses of BPA are listed in Supplemental Tables
3 and 4. The two doses resulted in opposing changes of
mRNA expression of genes involved in GABA synthesis
(glutamic acid decarboxylase, GAD), reuptake (GABA
transporter, GAT) and signaling (GABAA Receptor sub-
units) (Table 2). Using qPCR on a larger number of sam-
ples (n  8), the increase in mRNA expression of GAD2
was confirmed after 5 mg/kg.day of BPA (1.3  0.07 vs
1.04  0.09 in control). Likewise, the increased mRNA
expression of GAT2 was confirmed after 25 ng/kg.day of
BPA (1.5  0.27 vs 1.09  0.13 in control).
BPA exposure and GABAergic regulation of GnRH
release
Based on the RNA sequencing results, we studied
whether GABAergic regulation of pulsatile GnRH secre-
tion was affected by BPA. Exposure to the low BPA dose
from PND 1 to 15 resulted in a significant increase of
GnRH IPI on PND 20 (51.7 0.9 minutes vs 43.5 0.0
minutes)while thehighdose causeda significant reduction
of GnRH IPI (39.4 0.5minutes), confirming the data of
earlier experiments. The increase in GnRH IPI that oc-
curred after 25 ng/kg.day of BPA likely involved increased
GABAergic tonebecause itwasno longer observed (Figure
4) when hypothalamic explants were incubated in the
presence of bicuculline, a GABAA receptor antagonist
(45.8  0.9 minutes vs 51.65  0.9 minutes, bicuculline
vs control). Moreover, muscimol did not affect the in-
crease in GnRH IPI seen after exposure to 25 ng/kg.day of
BPA. The reduction in GnRH IPI that occurred after 5
mg/kg.day of BPA (43.8 1.3 minutes vs 40 1.25 min-
utes, muscimol vs control) was no longer observed when
hypothalamic explants were incubated in the presence of
muscimol, a GABAA receptor agonist. The GABAA recep-
tor antagonist did not affect the reduction in GnRH IPI
seen after exposure to 5 mg/kg.day of BPA (Figure 4).
Taken together, these data confirm that postnatal expo-
sure to a very low dose of BPA accounts for delayed mat-
uration of GnRH secretion through increased GABAergic
tone whereas a high dose of BPA accounts for early mat-
uration through reduced GABAergic tone.
Discussion
We provide here the first evidence that BPA can have op-
posing dose-dependent effects on the neuroendocrine con-
trol of puberty in the female rat. Postnatal exposure to a
high dose of BPA led to accelerated maturation of GnRH
secretion and a trend toward early onset of puberty. Con-
versely, neonatal exposure to a very low dose of BPA led
to a delay in developmental acceleration of GnRH secre-
tion anda trend towarddelayedvaginal opening. Basedon
these opposing effects on neuroendocrine maturation, we
hypothesized that some hypothalamic genes could be dif-
ferentially affected by a low vs high dose of BPA. An
RNAseq analysis showed opposing variations in mRNA
expression of genes related to GABA neurotransmission
with confirmation using qPCR. Using GABA agonist and
antagonist, a decrease or an increase of GABA inhibitory
tone on pulsatile GnRH secretion was shown after expo-
sure to a high or low dose of BPA, respectively.
As detailed in the Supplemental Table 5, a number of
studies have reported that GABA neurotransmission
could be affected in different brain areas after exposure to
BPA during early life (34–41). GABAergic tone appeared
Table 2. Genes related to GABA neurotransmission showing significant changes in hypothalamic mRNA expression






















GAD1 65.87 	0.19 0.05 665 0.35 0.00 065
GAD2 52.05 	0.24 0.01 670 0.44 0.00 005
GAT2 5.34 	0.60 0.0006 0.39 0.00 885
GABRA2 16.69 	0.18 0.10 665 0.45 0.0015
GABRB3 17.95 	0.16 0.1294 0.63 0.00 075
GABRD 20.44 	1.09 0.00 005 0.23 0.04 135
GABRE 6.49 	0.15 0.1965 0.71 0.00 005
GABRG2 43.47 	0.04 0.73 085 0.40 0.00 075
GABRG3 3.79 	0.88 0.0003 0.61 0.00 405
GABRQ 5.67 	0.21 0.07 385 0.70 0.00 005
GAD: Glutamic Acid Decarboxylase; GAT: GABA Transporter; GABR: GABA Receptor
FPKM: Fragments Per Kilobase Million (digital value of expression level).
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tobe increasedafterBPAexposure in some studies (34, 37)
or reduced in others (36, 38, 39). In a recent study close to
our conditions using whole brain extracts from animals
exposed to different doses of BPA from gestational day 8
to PND 16, Cabaton et al, investigated brain composition
by nuclear magnetic resonance spectroscopy on PND 21.
In this non targeted metabolomics study, these authors
reported that 25 g/kg.day of BPA could reduce GABA
concentrations in the brain (36). Interestingly enough they
also used a very low BPA dose of 25 ng/kg.day and it
appears that opposing effects were obtained with the low
dose ie, increase inGABAconcentrations (N.Cabatonand
D.Zalko, personal communication). These opposing dose
effects are consistent with the present study. Also, such an
observation in the whole CNS could suggest that the ef-
fects reported here about a specific neuroendocrine func-
tion could be part of a much larger effect of BPA in the
brain. Opposing dose effects of BPA are supported by in
vitro studies of GABA-induced currents in hippocampal
neurons that are inhibited or potentiated by high or low
BPA concentrations, respectively (41). It has been shown
that GnRH secretion can be regulated by GABA in two
manners (42). Synaptic receptors generate fast (phasic)
postsynaptic currents and extrasynaptic receptors gener-
ate a persistent (tonic) current controlling neuronal excit-
ability. The latter GABAA receptors accounting for tonic
current involve the delta subunit. Among the genes en-
coding the GABAA receptor subunits, mRNA expression
ofDelta subunit is the only one repressed after exposure to
5 mg/kg.day of BPA and one among two subunit genes
showing increased mRNA expression after 25 ng/kg.day
of BPA (Table 2). This is consistent with dose-dependent
dual effects of BPA on tonic GABA neurotransmission.
Only a few studies addressed the neuroendocrine events
that can precede or follow the changes in GABAergic tone
(Supplemental Table 5). Either two separate mechanisms
involving different factors or opposing variations of a
common factor could explain the opposing effects of BPA
on GABA neurotransmission. An insight into a possible
upstream mechanism was recently provided by a study
reporting that delayed neonatal maturation of a chloride
cotransporter after in utero exposure to BPA contributes
toactivateGABAneurotransmission through reductionof
intraneuronal chloride concentrations (40). The gene en-
coding this cotransporter (Kcc2) was not affected in our
RNAseq study performed on PND20. Studies performed
in younger animals with emphasis on epigenetic mecha-
nismsarewarrantedbecause suchmechanismswere found
to account for BPA alteration ofKcc2 expression (40) and
DNA methyltransferase 1 mRNA expression was altered
following BPA exposure in another study (39). In the pres-
ent study, DNMT1 mRNA expression in the female hy-
pothalamuswas found to increase significantly at PND20
after exposure to 5 mg/kg.day of BPA (data not shown).
Such effects consistent with involvement of epigenetic
mechanisms could suggest that BPA has organizational
together with activational effects. The issue is complex in
the reproductive axis since some effects are likely occur-
ring at other levels including the gonads (43, 44).
Changes in mRNA expression of the components of
GABAergic neurotransmission (GAD,GAT,GABAR) can
be viewed either as part of the altered GABAergic tone or
as a downstream reaction to the altered GABAergic tone.
In the first case, increased GAD and reduced GAT expres-
sion will be associated with increased GABAergic tone
(and conversely) such as found for GAD mRNA in the
basolateral amygdala (39). In the present study, the in-
verse observation was made since reduced GAD and in-
creased GAT expression were associated with increased
GABAergic tone (and conversely). Such findings can be
consistent with effects downstream from the increased
GABA tone because it was shown in neuronal culture that
GABA could down-regulate GAD expression and activity
(45) and up-regulate GAT activity (46). Confirmation of
such an explanation would require a time-lapse study of
GAD and GAT expression during and after exposure to
different doses of BPA.Aprerequisite to the interpretation
of changes in GAD and GAT mRNA expression was to
Figure 4. Effects of in vivo exposure to BPA on GABAergic regulation
of GnRH secretion in vitro. GnRH IPI was calculated using secretion
from hypothalamic explants obtained on PND 20 from female rats
exposed in vivo to vehicle (corn oil) or 25 ng/kg.day or 5 mg/kg.day of
BPA from PND 1 to 15. The in vitro conditions involve control or
presence of a GABAA receptor antagonist (bicuculline) or a GABAA
receptor agonist (muscimol) both used at 10-4 M concentration shown
previously to be effective in similar conditions. A reduction in GnRH IPI
by bicuculline and absent effects of muscimol indicated a high tone of
GABAergic inhibition of GnRH release. Absence of bicuculline effects
and increase in GnRH IPI by muscimol indicated a low tone of
GABAergic inhibition of GnRH release. *** P  .001. Data are mean
 SEM.
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clarifywhether theGABAergic control ofGnRHsecretion
was increased or reduced. An answer was obtained indi-
rectly using the GABAAR agonist muscimol and antago-
nist bicuculline. Interestingly, Zhou et al (38) also found
that the GABAAR agonist was effective in conditions of
BPA-induced reduction of GABAergic tone using another
paradigm, whereas the antagonist was effective in control
conditions. A body of literature shows that GABA is a
major contributor to the prepubertal inhibition of GnRH
secretion in several species (23). However, there is evi-
dence of stimulatoryGABA in adult rats andmice (47, 48)
and in the fetal hypothalamus (49). Since GABA has dual
effects on GnRH neurosecretion, one could hypothesize
that BPA resulted in increased or reducedGnRH secretion
through antagonism of inhibitory or stimulating GABA
inputs. In such event however, the effects ofmuscimol and
bicuculline would have been opposed. In addition, dual
GABA effects could be determined by the developmental
stage and the neuronal apparatus (GnRH neurons vs im-
pinging regulatory neurons). Here, opposing effects were
obtained in similar conditions of age and hypothalamic
structure.
Based on RNAseq data, G-Protein-coupled receptors
represent another mechanistic component that bioinfor-
matics analysis identified as a candidate system possibly
involved. This was particularly interesting given the crit-
ical stimulating role of GPR54 and its ligand kisspeptin in
the neuroendocrine control of puberty and reproduction
(50, 51). However, neither Kiss1 nor GPR54 mRNA ex-
pression appeared to be affected in the present RNAseq
analysis. We reported recently that DES exposure (1 and
10 g/kg.day) reduced KISS1 expression in the hypothal-
amus (18). In the present study however, exposure to BPA
did not affect KISS1 mRNA level in the mediobasal hy-
pothalamus (data not shown). After neonatal exposure of
female rats to 0.1 or 0.5 mg/kg.day of BPA for 5 days,
Navarro et al (9) reported reduced KISS1mRNA expres-
sion on PND 30 and Patisaul et al (52) found reduced
kisspeptin immunoreactivity in the arcuate nucleus after
neonatal exposure to 50 mg/kg.day of BPA for 4 days.
Because kisspeptin is a gatekeeper of GnRH neuron stim-
ulation, these findings are in contrast to the early vaginal
opening that was reported after neonatal or early postna-
tal exposure toBPAdoses ranging0.05–100mg/kg.day (4,
7, 8). These discordant findings could suggest that BPA
effects on kisspeptin are not causal in the mechanism of
early sexual maturation andmight be reactive to that pro-
cess, such as discussed about GAT and GAD mRNA
expression.
Several studies have reported an effect of BPA on pu-
bertal onset in female rodents. Taken as a whole, those
studies show that BPA effects dependmarkedly on the age
window and dose of exposure, with possible nonlinear
dose-response relationship (2, 53). Toour knowledge, our
study is the first one demonstrating the impact of such a
low and environmentally relevant dose of BPAon the neu-
roendocrine mechanism of sexual maturation. Twenty-
five ng/kg.day of BPA affect the frequency of GnRH se-
cretion and mRNAs expression of several hypothalamic
genes. The effect of the very low dose of BPA on frequency
of GnRH secretory pulses is robust and reproducible in
our model. Moreover, it is consistent with the trend to-
warddelayedVOthat is seen subsequently.The amplitude
ofGnRHsecretory pulses is not affected (data not shown).
Using the ex vivo paradigm of hypothalamic explant,
changes in amplitude ofGnRHreleasewere only apparent
after in vitro stimulation with secretagogues such as glu-
tamate or glutamate receptor agonists (21, 54). Since we
aimed at changes in endogenously driven pulsatile secre-
tion of GnRH in the present study, GnRH secretagogues
have not been used.
The neuroendocrine system appears to be exquisitely
sensitive to BPA endocrine disruption that may not be
manifested phenotypically.When the female rats are post-
natally exposed to 25 ng/kg.day for 5 or 15 days, age at
puberty is not significantly different from controls but the
frequency of GnRH secretion is significantly decreased.
Presumably, the effects on maturation of GnRH secretion
evidenced at PND 20 and 25 are not lasting enough or
sufficient to affect significantly pubertal timing about ten
days later. We made a similar observation in male rats
exposed for 5 days after birth (2). Thus, absence of phe-
notypic changes in some of the previous studies does not
necessarily mean absence of effect. Such high neuroendo-
crine sensitivity to BPA, functionally evidenced through
changes in pulsatile GnRH secretion, is also consistent
with a significant change in hypothalamic mRNA expres-
sion of 34 genes following exposure to that very low dose
of BPA.
The study of mRNAs expression showed some limita-
tions. Our RNAseq analysis was limited to 3 samples for
each group and confirmed on 8 samples only for some of
the genes involved in GABA synthesis, reuptake and sig-
naling. However, the incubation of control or BPA-ex-
posed hypothalamic explants with a GABA receptor ag-
onist or antagonist robustly confirmed the effects of BPA
on GABAergic neurotransmission. A short exposure of 5
or 15 days differs from the constant human exposure
throughout life. However, such short exposures allow the
delineation of a window of sensitivity to BPA. Also, the
effects of BPAon puberty are unlikely to result fromdirect
effects on target peripheral tissues such as the female gen-
ital tract because the exposure ended several weeks before
pubertyandBPA is anonpersisting chemical.Accordingly,
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the data are likely to reflect alterations of functions orga-
nized during early postnatal life.
Human exposure to BPA varies between 0.01 and 1
g/kg.day (10). Because we have studied a very low dose
of 25 ng/kg.day, we chose subcutaneous injections in or-
der to guarantee accuracy of the exposure. This route of
administration was used as well in all the other studies
with BPA exposure in early postnatal life (reviewed in (2)).
While not relevant to the human route of exposure, sub-
cutaneous injections have been shown to lead to similar
serum concentration as oral administration (55). The
question remains as to whether such a low level of expo-
suremakesadifference fromcontamination through food,
water and cages. We have attempted to control for this
through housing conditions and the control animals ex-
posed to corn oil were raised in similar conditions.
Postnatal life (5 to 15 first days after birth) has been
shown to be particularly sensitive to the effects of BPA on
the neuroendocrine mechanism of puberty (2). Further
studies could underscore the significance of early postna-
tal life as a critical window by comparing the effects of a
similar exposure to BPA in adulthood. Questions remain
as to whether a longer and sustained exposure involving
the whole prenatal life could result in effects similar to
those reported here.Moreover, further studies should aim
at delineation of the genetic mechanisms that take place
upstream and downstream to GABA neurotransmission
and account for divergent effects on pubertal timing.
In conclusion, our study shows that alteration of pu-
bertal timing by BPA in the rat is not necessarily towards
precocity. Instead, delayedmaturation ofGnRHsecretion
can be caused by environmentally relevant exposure with
themechanistic involvementofGABAneurotransmission.
Taking together our data and the literature, it appears that
the effects of BPA are not limited to the neuroendocrine
control of the reproductive axis. BPA seems to affect
GABAneurotransmission inmultiple brain areas. Though
rodent data do not necessarily apply as such to human
health, the involvement of GABA shown in the present
study points to the likelihood of detrimental effects of
early life exposure to BPA in humans. GABA plays indeed
a critical role in brain development and function and dis-
orders of human behaviors including autism (56) that are
possibly more frequent after early exposure to BPA (57–
59). The US Environmental Protection Agency (EPA) has
considered that a daily exposure lower than 50 g/kg.day
was “safe” (60). EFSA very recently proposed to set the
daily tolerable intake at 4 g/kg.day (61). This study re-
inforces the idea that defining a threshold for BPA effects
is misleading not only because doses much below the so-
called “safe” limit can interfere with the hormonal system
but also because a low and a high dose can have opposing
effects.
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